Back to search
Epithelioid Hemangioendothelioma (EHE)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Epithelioid Hemangioendothelioma (EHE) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Epithelioid Hemangioendothelioma (EHE) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a non-randomized, open label, single arm Phase II trial with a two-stage design with histologically-confirmed metastatic and/or recurrent epithelioid he…
The goal of this open-label, dose escalation and dose expansion Phase I clinical trial is to evaluate the safety, tolerability, pharmacokinetics and preliminary…
This research study is studying a drug as a possible treatment for Angiosarcoma or Epithelioid hemangioendothelioma (EHE). -The drug involved in this study is…
This is a Phase 1, first-in-human (FIH) clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antit…